The PennZone

  • Home
  • Business
  • Non-profit
  • Technology
  • Health
  • Real Estate
  • Entertainment
  • Travel
  • Manufacturing

Lineus Medical Announces a Reduction in Price for SafeBreak Vascular
The PennZone/10280788

Trending...
  • Michael Judkins Releases New Poetry Book, Deeper Than You Think
  • CNCPW Divulga Dados de Liquidez do 1º Trimestre: Confirma 100% de Reservas e Atualiza Protocolos de "Saque CNCPW" Contra Fluxos Ilícitos
  • Tech Workers Are Escaping "Forever Layoffs" By Becoming Their Own Boss
SafeBreak Vascular Lineus Medical
FAYETTEVILLE, Ark. - PennZone -- Lineus Medical announces a significant reduction in price of nearly 15% for its flagship product, SafeBreak Vascular, in the United States. After creating a new device classification with the FDA and becoming the first break-away device available for IV lines in the US, SafeBreak Vascular was first released with a list price of $6.90. Since its release, increased sales volume and concentrated efforts toward manufacturing efficiencies support a price adjustment with a new list price of $5.90, effective on September 1st, 2024.

SafeBreak Vascular is the only break-away device for IV lines proven to reduce IV complications1.  When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patent's infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money1.

More on The PennZone
  • EPP Pricing Platform announces leadership transition to support long-term growth and continuity
  • Stolen Hearts: Reclaiming Your Child From Parental Alienation (narcissistic abuse)
  • Roshni Online Services Unveils Plans for Innovative Digital Consultation Platform
  • VIP Vacations Named Winner Of The Knot Best Of Weddings 2026
  • Wall Street Is Missing This One: Cycurion (NAS DAQ: CYCU) Gets $7 Price Target While Trading at a Steep Discount

"A large focus of our strategy is maximizing our economic value proposition for the hospital." Lineus Medical's Vice President of Sales, Larry Hayes comments, "Reducing our price allows for both current and new accounts to take advantage of cost savings, and in doing so, we are making it easier for hospitals to invest in improved vascular access care for their patients."

Vance Clement, CEO of Lineus Medical, stated, "Inflation is hitting everyone, and we are all used to prices going up.  This is especially true in healthcare, where prices never go down. However, SafeBreak, which is proudly made in the USA, is changing that. As we continue to grow, we will keep investing in manufacturing so that we can lower the cost of SafeBreak again in the future."

Lineus Medical is committed to improving patient safety and advancing vascular access care and believes that this price reduction is another important step in our mission to remove the pains associated with medical lines.  Anyone interested in SafeBreak Vascular's price reduction can visit our website www.lineusmed.com to learn more.

About Lineus Medical

Lineus Medical is the developer of a break-away technology that is proven to reduce IV restarts and IV complications1. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn.

Contact
Vance Clement
***@lineusmed.com


Source: Lineus Medical

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Anatomy Naturals Earns Industry Recognition for Small-Batch Botanical Skincare
  • Market Value Enhancement From 2 Important New US Patents Issued for Strengthening Hair Enzyme Booster Technology to Caring Brands (NAS DAQ: CABR)
  • Scranton Fringe Launches "Social Media for Performing Artists" A Four-Week Workshop Series
  • HELM Audio™ Partners with PQCrypto to Future-Proof Children's Hearing and Safety Data Using Post-Quantum Cryptography
  • Wala Blegay to Announce Run for Congress in Maryland's 5th District on Feb. 4
  • IDI Consulting Launches IDI AI, Enterprise-Level AI Services Built for Production, Scale, and ROI
  • Luxury Lake-View Home Launches in Kissimmee's Bellalago community, Offering Privacy, Space, and Florida Resort-Style Living
  • Sleep Basil Launches Revamped Diamond Mattress Collection Page, Highlighting Performance, Craftsmanship, and Personalized Comfort
  • Sleep Basil Curates a Clearer Brooklyn Bedding Experience for Performance-Minded Denver Sleepers
  • Nevada Man Launches Nationwide Animal Abuse Registry
  • Star-powered Kappa Takeover Weekend Returns to the DMV June 18- 21, 2026, Hosted By Comedian Joe Clair W/ Dj Quick Silva (the Party Kingpin)
  • Scoop Social Co. Wins The Knot and WeddingWire Awards as Brand Expands Nationwide
  • Denise Murphy Lenci Promoted to Century Fasteners Corp. – General Manager, Northeast Sales
  • TiNY Puts Real Pets on the Payroll for New PetArmor Campaign
  • P‑Wave Classics Launches Definitive New Edition of Hannah Webster Foster's The Coquette
  • Strategic Expansion with 3 New Alliances — Jefferson Beach Yacht Sales, CFR YS & flyExclusive Incentive Partnership: Off The Hook YS: (N Y S E: OTH)
  • Super League (N A S D A Q: SLE) Advances AI-Driven Playable Media with AdArcade, Solsten, and Meta-Stadiums Partnerships, Plus Roblox Theatre Launch
  • purelyIV Expands Concierge Wellness Platform with New IV Therapies, Memberships, and Digital Experience
  • CCHR: Europe Rejects Forced Psychiatry—Landmark Vote Declares Coercive Practices Incompatible with Human Rights
  • Crossroads4Hope Kicks Off Its 25th Year of Caring with the Launch of Free Breast and Colorectal Cancer Resources for Patients and Families Nationwide

Popular on PennZone

  • Mark Schork Selected As 'Board Observer' By Philadelphia Bar Foundation - 107
  • Pawprint Oxygen Turns Pet Safety Viral With "Pets Live Here" Window Decals — Helping First Responders Save Lives
  • Bargeld Financial Launches Professional, Affordable Tax Preparation Services for the 2026 Tax Season
  • Food Journal Magazine Releases Its 'Best Food In Los Angeles Dining' Editorial Section
  • High-End Exterior House Painting in Boulder, Colorado
  • Yunishigawa Onsen's Annual "Kamakura Festival" will be held January 30 – March 1, 2026
  • Premium Bail Bonds Proudly Sponsors BOFAB BBQ Team at the 2026 Lakeland Pigfest
  • "Phinge Unveil™" Coming to Las Vegas to Showcase Netverse Patented Verified App-less Platform, AI & Modular Hardware Including Developer Conferences
  • $780,000 Project for New Middle East Police Service with Deposit Received and Preliminary Design Work Underway for Lamperd: Stock Symbol: LLLI
  • High-Impact Mental Health Platform Approaching a Defining Regulatory Moment: Eclipsing 70,000 Patients on Real World Use of Ketamine: N ASDAQ: NRXP

Similar on PennZone

  • NASA / Glenn Research Center Collaboration to Help Meet Rising Demand for Space Energy Beaming Tech / CIGS PV Modules from Ascent Solar: NAS DAQ: ASTI
  • When Interpretation Becomes Conversation: Rethinking Engagement in the Museum Age
  • RTC Communications Completes Next Level Connect Fiber Expansion Bringing Multi-Gig Broadband to West Boggs Community
  • Roshni Online Services Unveils Plans for Innovative Digital Consultation Platform
  • Wall Street Is Missing This One: Cycurion (NAS DAQ: CYCU) Gets $7 Price Target While Trading at a Steep Discount
  • Aries Industries Streamlines Sewer Inspection Process With Introduction of the LETS Sidewinder
  • Chronic Boss Awards Scholarships to Student Founders Living with Chronic Conditions
  • Market Value Enhancement From 2 Important New US Patents Issued for Strengthening Hair Enzyme Booster Technology to Caring Brands (NAS DAQ: CABR)
  • Wala Blegay to Announce Run for Congress in Maryland's 5th District on Feb. 4
  • IDI Consulting Launches IDI AI, Enterprise-Level AI Services Built for Production, Scale, and ROI
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us